Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications
Immunotherapy has emerged as a powerful approach in treating various diseases, yet its success often hinges on the efficacy of adjuvants, agents that boost immune responses to therapeutic targets. Traditional adjuvants have offered foundational support but may fall short in achieving the specificity...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Biomaterials Science |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fbiom.2025.1544465/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1823856627889995776 |
|---|---|
| author | Nimeet Desai Sherrin Gotru Sagar Salave Lalitkumar K. Vora |
| author_facet | Nimeet Desai Sherrin Gotru Sagar Salave Lalitkumar K. Vora |
| author_sort | Nimeet Desai |
| collection | DOAJ |
| description | Immunotherapy has emerged as a powerful approach in treating various diseases, yet its success often hinges on the efficacy of adjuvants, agents that boost immune responses to therapeutic targets. Traditional adjuvants have offered foundational support but may fall short in achieving the specificity and potency required for advanced therapies. This review highlights a new generation of adjuvants poised to address these limitations. We explore a range of innovative agents, including non-inflammatory nucleic acid adjuvants, bacterial derivatives, and synthetic molecules, which are redefining the role of adjuvants in immunotherapy. These emerging agents hold promise for enhancing immune responses while tailoring therapies to specific disease contexts, from cancer to infectious diseases. By examining the applications and potential of these adjuvants, this review aims to provide a comprehensive understanding of how they can advance immunotherapy to new levels of efficacy and precision. Through the development of these novel adjuvants, immunotherapy stands to achieve more targeted and sustained impacts, paving the way for improved outcomes in patient care. |
| format | Article |
| id | doaj-art-e6ed882f81ba4bf4a3ca239e43bd8333 |
| institution | Kabale University |
| issn | 2813-3749 |
| language | English |
| publishDate | 2025-02-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Biomaterials Science |
| spelling | doaj-art-e6ed882f81ba4bf4a3ca239e43bd83332025-02-12T07:26:16ZengFrontiers Media S.A.Frontiers in Biomaterials Science2813-37492025-02-01410.3389/fbiom.2025.15444651544465Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applicationsNimeet Desai0Sherrin Gotru1Sagar Salave2Lalitkumar K. Vora3Department of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Gandhinagar, IndiaDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Gandhinagar, IndiaDepartment of Pharmaceutics, National Institute of Pharmaceutical Education and Research-Ahmedabad (NIPER-A), Gandhinagar, IndiaSchool of Pharmacy, Queen’s University Belfast, Belfast, United KingdomImmunotherapy has emerged as a powerful approach in treating various diseases, yet its success often hinges on the efficacy of adjuvants, agents that boost immune responses to therapeutic targets. Traditional adjuvants have offered foundational support but may fall short in achieving the specificity and potency required for advanced therapies. This review highlights a new generation of adjuvants poised to address these limitations. We explore a range of innovative agents, including non-inflammatory nucleic acid adjuvants, bacterial derivatives, and synthetic molecules, which are redefining the role of adjuvants in immunotherapy. These emerging agents hold promise for enhancing immune responses while tailoring therapies to specific disease contexts, from cancer to infectious diseases. By examining the applications and potential of these adjuvants, this review aims to provide a comprehensive understanding of how they can advance immunotherapy to new levels of efficacy and precision. Through the development of these novel adjuvants, immunotherapy stands to achieve more targeted and sustained impacts, paving the way for improved outcomes in patient care.https://www.frontiersin.org/articles/10.3389/fbiom.2025.1544465/fullimmunotherapyadjuvantsvaccinecancerinfectious diseases |
| spellingShingle | Nimeet Desai Sherrin Gotru Sagar Salave Lalitkumar K. Vora Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications Frontiers in Biomaterials Science immunotherapy adjuvants vaccine cancer infectious diseases |
| title | Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications |
| title_full | Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications |
| title_fullStr | Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications |
| title_full_unstemmed | Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications |
| title_short | Vaccine adjuvants for immunotherapy: type, mechanisms and clinical applications |
| title_sort | vaccine adjuvants for immunotherapy type mechanisms and clinical applications |
| topic | immunotherapy adjuvants vaccine cancer infectious diseases |
| url | https://www.frontiersin.org/articles/10.3389/fbiom.2025.1544465/full |
| work_keys_str_mv | AT nimeetdesai vaccineadjuvantsforimmunotherapytypemechanismsandclinicalapplications AT sherringotru vaccineadjuvantsforimmunotherapytypemechanismsandclinicalapplications AT sagarsalave vaccineadjuvantsforimmunotherapytypemechanismsandclinicalapplications AT lalitkumarkvora vaccineadjuvantsforimmunotherapytypemechanismsandclinicalapplications |